Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

The study reports that people are finding drugs like Ozempic and Wegovy helpful to manage cravings, not just for food, but ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of obesity was seen for children and adolescents, according to data published ...

A decades-long study of Danish conscripts finds that despite the rise in obesity, the inverse relationship between intelligence and BMI has remained unchanged.

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

High consumption of ultraprocessed foods containing high levels of added sugars, saturated fat, and sodium is associated with obesity in early childhood, especially in boys.